RU2756767C2 - Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения - Google Patents
Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения Download PDFInfo
- Publication number
- RU2756767C2 RU2756767C2 RU2019136252A RU2019136252A RU2756767C2 RU 2756767 C2 RU2756767 C2 RU 2756767C2 RU 2019136252 A RU2019136252 A RU 2019136252A RU 2019136252 A RU2019136252 A RU 2019136252A RU 2756767 C2 RU2756767 C2 RU 2756767C2
- Authority
- RU
- Russia
- Prior art keywords
- vaccine
- infection
- immunogen
- prrs
- pcv2
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 102
- 244000052769 pathogen Species 0.000 title description 24
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims abstract description 80
- 241001465754 Metazoa Species 0.000 claims abstract description 57
- 208000015181 infectious disease Diseases 0.000 claims abstract description 52
- 241001673669 Porcine circovirus 2 Species 0.000 claims abstract description 46
- 230000002163 immunogen Effects 0.000 claims abstract description 39
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims abstract description 31
- 241000700605 Viruses Species 0.000 claims abstract description 30
- 230000003362 replicative effect Effects 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000002238 attenuated effect Effects 0.000 claims abstract description 13
- 241001148567 Lawsonia intracellularis Species 0.000 claims description 15
- 238000011321 prophylaxis Methods 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 230000009385 viral infection Effects 0.000 claims description 6
- 210000004207 dermis Anatomy 0.000 claims description 4
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims description 3
- 101710130262 Probable Vpr-like protein Proteins 0.000 claims description 3
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 238000011282 treatment Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract 1
- 241000282887 Suidae Species 0.000 description 28
- 238000002255 vaccination Methods 0.000 description 28
- 241001469654 Lawsonia <weevil> Species 0.000 description 21
- 230000001717 pathogenic effect Effects 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 241000282898 Sus scrofa Species 0.000 description 10
- 239000000427 antigen Substances 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 241001661006 Pepper cryptic virus 2 Species 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- 230000028993 immune response Effects 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000011529 RT qPCR Methods 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 108090000565 Capsid Proteins Proteins 0.000 description 3
- 102100023321 Ceruloplasmin Human genes 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 241000202347 Porcine circovirus Species 0.000 description 3
- 206010058874 Viraemia Diseases 0.000 description 3
- 210000004081 cilia Anatomy 0.000 description 3
- 210000001842 enterocyte Anatomy 0.000 description 3
- 208000009326 ileitis Diseases 0.000 description 3
- 210000003405 ileum Anatomy 0.000 description 3
- 238000007918 intramuscular administration Methods 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000005753 Circoviridae Infections Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000710788 Lelystad virus Species 0.000 description 2
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229940001442 combination vaccine Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229960005030 other vaccine in atc Drugs 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000011886 postmortem examination Methods 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 2
- 241000701447 unidentified baculovirus Species 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 101000977023 Azospirillum brasilense Uncharacterized 17.8 kDa protein in nodG 5'region Proteins 0.000 description 1
- 101000961984 Bacillus thuringiensis Uncharacterized 30.3 kDa protein Proteins 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 208000031531 Desulfovibrionaceae Infections Diseases 0.000 description 1
- 101000644901 Drosophila melanogaster Putative 115 kDa protein in type-1 retrotransposable element R1DM Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 101000747702 Enterobacteria phage N4 Uncharacterized protein Gp2 Proteins 0.000 description 1
- 101000758599 Escherichia coli Uncharacterized 14.7 kDa protein Proteins 0.000 description 1
- 241001662043 Icterus Species 0.000 description 1
- 101710128560 Initiator protein NS1 Proteins 0.000 description 1
- 101000768930 Lactococcus lactis subsp. cremoris Uncharacterized protein in pepC 5'region Proteins 0.000 description 1
- 101000976302 Leptospira interrogans Uncharacterized protein in sph 3'region Proteins 0.000 description 1
- 101000778886 Leptospira interrogans serogroup Icterohaemorrhagiae serovar Lai (strain 56601) Uncharacterized protein LA_2151 Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 241001292005 Nidovirales Species 0.000 description 1
- 101710144127 Non-structural protein 1 Proteins 0.000 description 1
- 101710113540 ORF2 protein Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710090523 Putative movement protein Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010038669 Respiratory arrest Diseases 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 101001121571 Rice tungro bacilliform virus (isolate Philippines) Protein P2 Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101000818098 Spirochaeta aurantia Uncharacterized protein in trpE 3'region Proteins 0.000 description 1
- 101001026590 Streptomyces cinnamonensis Putative polyketide beta-ketoacyl synthase 2 Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101000750896 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized protein Synpcc7942_2318 Proteins 0.000 description 1
- 208000010399 Wasting Syndrome Diseases 0.000 description 1
- 101000916321 Xenopus laevis Transposon TX1 uncharacterized 149 kDa protein Proteins 0.000 description 1
- 101000760088 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 20.9 kDa protein Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940028617 conventional vaccine Drugs 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 208000037902 enteropathy Diseases 0.000 description 1
- 244000309457 enveloped RNA virus Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940124590 live attenuated vaccine Drugs 0.000 description 1
- 229940023012 live-attenuated vaccine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000007433 macroscopic evaluation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000420 mucociliary effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 244000309711 non-enveloped viruses Species 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17166590 | 2017-04-13 | ||
| EP17166590.4 | 2017-04-13 | ||
| PCT/EP2018/059389 WO2018189290A1 (en) | 2017-04-13 | 2018-04-12 | Vaccines containing swine pathogens for associated non-mixed use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2019136252A RU2019136252A (ru) | 2021-05-13 |
| RU2019136252A3 RU2019136252A3 (cg-RX-API-DMAC10.html) | 2021-05-13 |
| RU2756767C2 true RU2756767C2 (ru) | 2021-10-05 |
Family
ID=58547447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019136252A RU2756767C2 (ru) | 2017-04-13 | 2018-04-12 | Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11311614B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4335455A3 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7665289B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102724420B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN110446502B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3058281A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX390682B (cg-RX-API-DMAC10.html) |
| RU (1) | RU2756767C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018189290A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3058281A1 (en) * | 2017-04-13 | 2018-10-18 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
| MX2022013080A (es) * | 2020-04-20 | 2022-11-10 | Intervet Int Bv | Una combinacion de vacunas para el tratamiento profilactico de un cerdo. |
| US20230241198A1 (en) * | 2020-07-24 | 2023-08-03 | Boehringer Ingelheim Animal Health USA Inc. | Combination porcine vaccine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2166327C2 (ru) * | 1995-05-15 | 2001-05-10 | Берингер Ингельгейм Корпорейшн | Вакцинная композиция против репродуктивного и респираторного синдрома свиней (prrs) и способ ее получения, способ иммунизации свиней |
| WO2009127684A1 (en) * | 2008-04-18 | 2009-10-22 | Intervet International B.V. | Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002026250A2 (en) * | 2000-09-29 | 2002-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Vaccines for proliferative ileitis |
| CA2587321A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved prrs vaccines |
| CN101277717A (zh) | 2005-09-09 | 2008-10-01 | 英特威国际有限公司 | Pcv-2疫苗 |
| CA2635430A1 (en) | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| WO2015082457A1 (en) | 2013-12-03 | 2015-06-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
| PL3076996T3 (pl) * | 2013-12-03 | 2020-05-18 | Intervet International B.V. | Szczepionka przeciwko cirkowirusowi świń typu 2 |
| KR102360690B1 (ko) | 2013-12-03 | 2022-02-08 | 인터벳 인터내셔널 비.브이. | Ｐｒｒｓ 및 로소니아 인트라셀룰라리스에 대한 돼지 백신 |
| US20200023128A1 (en) * | 2016-12-22 | 2020-01-23 | Intervet Inc. | Needleless injector |
| CA3058281A1 (en) * | 2017-04-13 | 2018-10-18 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
-
2018
- 2018-04-12 CA CA3058281A patent/CA3058281A1/en active Pending
- 2018-04-12 CN CN201880022778.9A patent/CN110446502B/zh active Active
- 2018-04-12 EP EP23217834.3A patent/EP4335455A3/en active Pending
- 2018-04-12 RU RU2019136252A patent/RU2756767C2/ru active
- 2018-04-12 US US16/604,188 patent/US11311614B2/en active Active
- 2018-04-12 MX MX2019012220A patent/MX390682B/es unknown
- 2018-04-12 KR KR1020197029516A patent/KR102724420B1/ko active Active
- 2018-04-12 JP JP2019555621A patent/JP7665289B2/ja active Active
- 2018-04-12 WO PCT/EP2018/059389 patent/WO2018189290A1/en not_active Ceased
- 2018-04-12 EP EP18719484.0A patent/EP3609533A1/en not_active Ceased
-
2022
- 2022-12-06 JP JP2022194985A patent/JP2023025210A/ja not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2166327C2 (ru) * | 1995-05-15 | 2001-05-10 | Берингер Ингельгейм Корпорейшн | Вакцинная композиция против репродуктивного и респираторного синдрома свиней (prrs) и способ ее получения, способ иммунизации свиней |
| WO2009127684A1 (en) * | 2008-04-18 | 2009-10-22 | Intervet International B.V. | Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus |
Non-Patent Citations (3)
| Title |
|---|
| FLEXFAMILY Mixing Guides", 11 March 2016 (2016-03-11), http://www.bi-vetmedica.com/sites/default/files/dam/internet/ah/vetmedica/com_EN/images/swine/FLEX%20Family%20Mixing%20Guide.pdf XP002773133, весь документ. * |
| FLEXFAMILY Mixing Guides", 11 March 2016 (2016-03-11), http://www.bi-vetmedica.com/sites/default/files/dam/internet/ah/vetmedica/com_EN/images/swine/FLEX%20Family%20Mixing%20Guide.pdf XP002773133, весь документ. WO /2009/ 127684 А, 22.10.2009. * |
| ИНСТРУКЦИЯ по применению вакцины "Порцилис PCV M Hyo" (Вакцина против цирковирусной инфекции и микоплазмоза (энзоотической пневмонии) свиней инактивированная эмульгированная, 30 сентября 2016 г., весь документ) (http://konsulagro.by/assets/konsul/files/instr/%D0%92-%D0%BD%20%D0%9F%D0%BE%D1%80%D1%86%D0%B8%D0%BB%D0%B8%D1%81%20PCV%20m%20hyo.pdf. * |
Also Published As
| Publication number | Publication date |
|---|---|
| MX390682B (es) | 2025-03-21 |
| EP4335455A2 (en) | 2024-03-13 |
| KR102724420B1 (ko) | 2024-10-30 |
| JP2020513027A (ja) | 2020-04-30 |
| MX2019012220A (es) | 2019-12-09 |
| EP4335455A3 (en) | 2024-05-22 |
| JP7665289B2 (ja) | 2025-04-21 |
| CA3058281A1 (en) | 2018-10-18 |
| CN110446502B (zh) | 2024-01-26 |
| RU2019136252A (ru) | 2021-05-13 |
| WO2018189290A1 (en) | 2018-10-18 |
| RU2019136252A3 (cg-RX-API-DMAC10.html) | 2021-05-13 |
| JP2023025210A (ja) | 2023-02-21 |
| US20200046825A1 (en) | 2020-02-13 |
| CN110446502A (zh) | 2019-11-12 |
| EP3609533A1 (en) | 2020-02-19 |
| US11311614B2 (en) | 2022-04-26 |
| KR20190134650A (ko) | 2019-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10780156B2 (en) | Treatment of pigs with PCV2 antigen | |
| KR102003620B1 (ko) | Pcv/마이코플라즈마 하이요뉴모니아 조합 백신 | |
| US9987348B2 (en) | PCV2B divergent vaccine composition and methods of use | |
| JP6907227B2 (ja) | Ｐｃｖ２ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン | |
| TW201828982A (zh) | 抗豬小病毒及豬生殖與呼吸道症候群病毒之疫苗及其製造方法 | |
| WO2008121958A1 (en) | Use of prrsv vaccines to reduce pcv2 viremia | |
| JP2023025210A (ja) | 組合せ非混合使用のためのブタ病原体含有ワクチン | |
| JP2020514266A (ja) | 豚用混合ワクチン | |
| US12594328B2 (en) | Combination of vaccines to prophylactically treat a pig | |
| JP7558638B2 (ja) | Ｐｃｖ２およびｐｒｒｓウイルス感染に対する皮内適用のためのワクチン | |
| RU2834834C1 (ru) | Комбинация вакцин для профилактического лечения свиней | |
| JP2019509302A (ja) | アルブミンを含むｐｃｖ２及びｐｒｒｓウイルス感染症に対する混合ワクチン |